---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-025851"
form_type: "8-K"
ticker: "AAME"
cik: "0000008177"
company_name: "ATLANTIC AMERICAN CORP"
filed_at: "2024-05-14T23:59:59+00:00"
generated_at: "2026-06-02T01:35:21.248639+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Atlantic American Q1 net loss widens to $2.0M; premium revenue falls 3.4%

## Summary
- Net loss of $2.0M ($0.10 per share) vs. loss of $1.4M ($0.08) in Q1 2023.
- Premium revenue decreased $1.5M to $44.6M, down 3.4% year-over-year.
- Operating loss of $2.4M compared to operating income of $0.6M a year ago.
- Life and health operations drove the loss on lower premiums and unfavorable claims; P&C performed well.
- Management highlighted new business initiatives and expanded sales in Atlantic Capital Life Assurance.

## SEC filing metadata
- accession: 0001140361-24-025851
- form_type: 8-K
- ticker: AAME
- cik: 0000008177
- company_name: ATLANTIC AMERICAN CORP
- filed_at: 2024-05-14T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/8177/000114036124025851/0001140361-24-025851-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/8177/000114036124025851/ef20029014_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-025851
- JSON: https://secwatch.observer/filing/0001140361-24-025851.json
- Plain text: https://secwatch.observer/filing/0001140361-24-025851.txt

## Key facts
- Earnings Releases
  ATLANTIC AMERICAN CORP reported first quarter ended March 31, 2024 results: revenue $44.6 million, net income net loss of $2.0 million, or ($0.10) per common share, EPS ($0.10) per common share.
  - Period: first quarter ended March 31, 2024
  - Revenue: $44.6 million
  - Net income: net loss of $2.0 million, or ($0.10) per common share
  - EPS: ($0.10) per common share
  - Result: reported results
  source text: coupled with unfavorable loss experience in the life and health operations. Premium revenue for the three month period ended March 31, 2024 decreased $1.5 million, or 3.4%, to $44.6 million from $46.1 million in the three month period ended March 31, 2023. The Company reported operating loss (as defined below) of $2.4 million in the three month period ended March
  evidence_url: https://www.sec.gov/Archives/edgar/data/8177/000114036124025851/0001140361-24-025851-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.